Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(14):1192-1193; doi:10.1093/jnci/91.14.1192
© 1999 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 14, 1192-1193, July 21, 1999
© 1999 Oxford University Press


NEWS

Awards, Appointments, Announcements

Cancer Care, Inc., New York, recently honored four individuals for their work against cancer. The honorees were:

Wayne P. Yetter, president and chief executive officer of Novartis Pharmaceutical Corp., for his friendship to the organization and for his extraordinary leadership in the field of cancer research."



View larger version (105K):
[in this window]
[in a new window]
 
Wayne P. Yetter, right, with Louis A. Guzzetti, president, Cancer Care, Inc., and Diane Blum, executive director, Cancer Care, Inc.

 
Lynne Ronon, senior vice president, Saks Fifth Avenue, New York, for her work "to marshal formidable awareness of and support for the battle against cancer," a cause to which her company has been dedicated.



View larger version (129K):
[in this window]
[in a new window]
 
Lynn Ronon with Phil Miller, Saks Fifth Avenue chairman and chief executive officer.

 
Amy M. Spindler, style editor, New York Times Magazine, for bringing "dignity and a personal voice to the fight against cancer."



View larger version (113K):
[in this window]
[in a new window]
 
Amy M. Spindler, left, and Anna Quindlen

 
Anna Quindlen, Pulitzer-Prize winning columnist for New York Times and novelist, for bringing "information, hope, and enlightenment to people whose lives have been touched by cancer."

Bowman Award

The San Antonio (Tex.) Cancer Institute announced that Claudia Gravekamp Ph.D., received the third annual Barbara H. Bowman Award for Cancer Prevention Research. The award carries a prize of $20,000.

Gravekamp is a member of the Tumor Immunology Laboratory in the Institute for Drug Development at the Cancer Therapy & Research Center and the University of Texas Health Science Center, San Antonio.

Friedman to Searle

G. D. Searle & Co., the Chicago-based pharmaceutical firm, named Michael A. Friedman, M.D., as senior vice president for clinical affairs, effective this month. He leaves the U.S. Food and Drug Administration where he served in several roles, including acting commissioner.

In addition to his role as acting commissioner, Friedman was lead deputy commissioner and deputy operations commissioner at FDA. Earlier, he was director of the Cancer Therapy Evaluation Program at the National Cancer Institute.

Donna Shalala, secretary of the U.S. Department of Health and Human Services, said in a statement that she "applauded Mike for his exemplary service." She also said he had "distinguished himself as a leader not only within the ranks of government, but in the medical, academic, science, and research communities as well."

Cassileth to MSK

The Memorial Sloan-Kettering Cancer Center, New York, named Barrie R. Cassileth, Ph.D., as chief of the Integrative Medicine Service, a new unit that will address patients' quality of life through mind and body healing regimens.



View larger version (136K):
[in this window]
[in a new window]
 
Dr. Barrie R. Cassileth

 
Most recently, Cassileth has been an adjunct faculty member at Duke University, Durham, N.C., and a visiting lecturer at Harvard University, Boston.

Two Named in San Antonio

The Cancer Therapy & Research Center, San Antonio, Tex., recently promoted Gina Mangold to the position of director of research administration and named Michael Davis vice president and chief development officer.

Mangold has been with CTRC 6 years and had been associate director of research administration. Davis, who takes the job as CTRC begins a $26 million fund-raising drive, had been at Southwest Texas State University.

Weisman Named in Milwaukee

The Medical College of Wisconsin, Milwaukee, named Steven J. Weisman, M.D., as professor of anesthesiology and professor of pediatrics.

He continues as the Jane B. Pettit Chair in Pain Management, director of the Pettit Comprehensive Pain Program, and associate director of pediatric anesthesiology at Children's Hospital of Wisconsin, Milwaukee.

AICR Appointment

The American Institute for Cancer Research, Washington, D.C., named Jeffrey R. Prince as its vice president for communications. In the past, Prince has been with the National Restaurant Association and the Food Marketing Institute.

AICR focuses its work on the link between diet, nutrition, and cancer, and supports research in cancer prevention and treatment.

Gyn Cancer Month

The Gynecologic Cancer Foundation, Chicago, and the American Hospital Assn., Chicago, are declaring that September will be the first annual Gynecologic Cancer Awareness month as a way of educating people about the diseases.

During September, individuals can obtain a free, confidential cancer risk assessment from the Woman's Cancer Network web site (www.wcn.org) and can call the foundation's toll-free phone number (1-800-444-4441) to get free gynecologic cancer information.

New Web Site

The Cure for Lymphoma Foundation, New York, opened a new web site in June (www.cfl.org) to provide information on lymphomas research, treatment, care, and support.

Information is available for both patients and professionals.

Gore Cancer Proposal

In a campaign policy address last month, Vice President Al Gore, who is campaigning for the U.S. presidency, said he would propose doubling over 5 years the funding for cancer research supported by the National Institutes of Health. He also proposed to double the progress over the next 10 years in reducing cancer deaths and new cancer cases in the United States.

The vice president also called for identifying by 2002 every gene that predisposes people to cancer, developing precise blood tests for virtually every cancer within 5 years to revolutionize early detection, and developing diagnostic tests for virtually every cancer within 5 years.

He also wants to increase the number of patients entering National Cancer Institute-supported clinical trials by 500% (to 120,000 patients) in 5 years. He called for legislation to assure that patients covered by Medicare can participate in clinical trials and to require all health plans to allow their beneficiaries to participate in clinical trials.

Gore also proposed expanding access to mammograms, colorectal screening, and other screening tests by enhancing low-cost screening programs run by the U.S. Centers for Disease Control and Prevention.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?